Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $458.10 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $205.42 | 2 | $0 (2023) |
| UCB, Inc. | $124.99 | 1 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $26.40 | 1 | $0 (2018) |
| Biogen, Inc. | $25.67 | 1 | $0 (2020) |
| Janssen Biotech, Inc. | $20.86 | 1 | $0 (2023) |
| Taro Pharmaceuticals USA, Inc. | $20.33 | 1 | $0 (2018) |
| ABIOMED | $18.42 | 1 | $0 (2024) |
| Bausch Health US, LLC | $16.01 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $143.41 | 2 | UCB, Inc. ($124.99) |
| 2023 | $123.03 | 2 | Janssen Scientific Affairs, LLC ($102.17) |
| 2022 | $103.25 | 1 | Janssen Scientific Affairs, LLC ($103.25) |
| 2020 | $25.67 | 1 | Biogen, Inc. ($25.67) |
| 2019 | $16.01 | 1 | Bausch Health US, LLC ($16.01) |
| 2018 | $46.73 | 2 | Janssen Pharmaceuticals, Inc ($26.40) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/16/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Neurology | ||||||
| 07/11/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $18.42 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/20/2023 | Janssen Scientific Affairs, LLC | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $102.17 | General |
| Category: Oncology | ||||||
| 09/14/2023 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Oncology | ||||||
| 09/30/2022 | Janssen Scientific Affairs, LLC | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $103.25 | General |
| Category: Oncology | ||||||
| 02/29/2020 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | In-kind items and services | $25.67 | General |
| Category: NEUROLOGY | ||||||
| 07/29/2019 | Bausch Health US, LLC | MIGRANAL (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: NEUROLOGY | ||||||
| 12/06/2018 | Taro Pharmaceuticals USA, Inc. | ULTRAVATE (halobetasol propionate) lotion (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Dermatology | ||||||
| 04/24/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $26.40 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 121 | 327 | $294,954 | $56,940 |
| 2022 | 2 | 236 | 509 | $417,196 | $85,439 |
| 2021 | 3 | 196 | 474 | $348,344 | $73,991 |
| 2020 | 3 | 133 | 212 | $153,488 | $33,240 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 121 | 327 | $294,954 | $56,940 | 19.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 197 | 449 | $396,916 | $80,226 | 20.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 39 | 60 | $20,280 | $5,213 | 25.7% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 134 | 362 | $310,596 | $64,367 | 20.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 46 | 90 | $29,520 | $7,638 | 25.9% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2021 | 16 | 22 | $8,228 | $1,986 | 24.1% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 23 | 68 | $72,012 | $13,452 | 18.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 70 | 71 | $51,546 | $13,000 | 25.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 40 | 73 | $29,930 | $6,788 | 22.7% |
About Dr. Jaspreet Mann, DO
Dr. Jaspreet Mann, DO is a Neurocritical Care healthcare provider based in Sacramento, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/20/2009. The National Provider Identifier (NPI) number assigned to this provider is 1003041054.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jaspreet Mann, DO has received a total of $458.10 in payments from pharmaceutical and medical device companies, with $143.41 received in 2024. These payments were reported across 9 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($458.10).
As a Medicare-enrolled provider, Mann has provided services to 686 Medicare beneficiaries, totaling 1,522 services with total Medicare billing of $249,610. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Neurocritical Care
- Other Specialties Neurology, Neurology
- Location Sacramento, CA
- Active Since 05/20/2009
- Last Updated 08/12/2021
- Taxonomy Code 2084A2900X
- Entity Type Individual
- NPI Number 1003041054
Products in Payments
- DARZALEX (Biological) $226.28
- Briviact (Drug) $124.99
- XARELTO (Drug) $26.40
- SPINRAZA (Biological) $25.67
- ULTRAVATE (halobetasol propionate) lotion (Drug) $20.33
- Impella (Device) $18.42
- MIGRANAL (Drug) $16.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurocritical Care Doctors in Sacramento
Dr. Steven Yang, D.o, D.O
Neurocritical Care — Payments: $776.84
Dr. Krupa Savalia, M.d., Ph.d, M.D., PH.D
Neurocritical Care — Payments: $278.18
Jeffrey Vitt
Neurocritical Care — Payments: $56.10
Saad Yazdani
Neurocritical Care — Payments: $42.41